Esophageal irritation due to alendronate sodium tablets: possible mechanisms - PubMed (original) (raw)

Esophageal irritation due to alendronate sodium tablets: possible mechanisms

C P Peter et al. Dig Dis Sci. 1998 Sep.

Abstract

Animal studies were done using an in vivo dog model to examine the possible mechanism for the esophageal adverse events reported with alendronate sodium tablets. These studies showed that under low pH conditions alendronate sodium can cause esophageal irritation. No esophageal irritation occurred at pH 3.5 or higher where the drug exists primarily as the sodium salt. The animal studies also showed that alendronate sodium can exacerbate preexisting esophageal damage. Exposure of the esophageal mucosa for a prolonged period to alendronate sodium tablet can also cause mild esophageal irritation. These findings suggest that the esophageal irritation in patients taking Fosamax can be from prolonged contact with the tablet, reflux of acidic gastric contents with alendronate sodium, and exacerbation of preexisting esophageal damage. The findings also suggest that other bisphosphonates can cause esophageal injury under similar conditions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1996 Oct 3;335(14 ):1016-21 - PubMed
    1. South Med J. 1977 Nov;70(11):1327-9 - PubMed
    1. N Engl J Med. 1995 Nov 30;333(22):1437-43 - PubMed
    1. Osteoporos Int. 1994 Nov;4(6):320-2 - PubMed
    1. Bone. 1992;13(5):351-4 - PubMed

MeSH terms

Substances

LinkOut - more resources